Merck KGaA (Merck KGaA) EV-to-EBIT

: 18.48 (As of Today)

View and export this data going back to 2007. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Merck KGaA's Enterprise Value is $76,022 Mil. Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $4,113 Mil. Therefore, Merck KGaA's EV-to-EBIT for today is 18.48.

The historical rank and industry rank for Merck KGaA's EV-to-EBIT or its related term are showing as below:

MKKGY' s EV-to-EBIT Range Over the Past 10 Years
Min: 14.51 Med: 21.83 Max: 31.26
Current: 18.45

During the past 13 years, the highest EV-to-EBIT of Merck KGaA was 31.26. The lowest was 14.51. And the median was 21.83.

MKKGY's EV-to-EBIT is ranked worse than
56.29% of 668 companies
in the Drug Manufacturers industry
Industry Median: 16.995 vs MKKGY: 18.45

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Merck KGaA's Enterprise Value for the quarter that ended in Dec. 2023 was $78,060 Mil. Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $4,113 Mil. Merck KGaA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5.27%.

Merck KGaA EV-to-EBIT Historical Data

The historical data trend for Merck KGaA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

26.42

23.86

25.72

19.35

18.55

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT																19.35	18.65	17.74	19.32	18.55

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA EV-to-EBIT Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Merck KGaA's EV-to-EBIT falls into.

Merck KGaA EV-to-EBIT Calculation

Merck KGaA's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	76021.650	/	4113.222
	=	18.48

Merck KGaA's current Enterprise Value is $76,022 Mil.
Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,113 Mil.

Merck KGaA (OTCPK:MKKGY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Merck KGaA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	4113.222	/	78060.0717
	=	5.27 %

Merck KGaA's Enterprise Value for the quarter that ended in Dec. 2023 was $78,060 Mil.
Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,113 Mil.

Merck KGaA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Merck KGaA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.